Skip to main content

Table 1 Study characteristics of included articles investigating postural stability in single-leg stance

From: Single-Leg Assessment of Postural Stability After Anterior Cruciate Ligament Injury: a Systematic Review and Meta-Analysis

Study

Country

Group

Sample size

Sex

Age, years (mean ± SD/range)

Time from:

1) Injury-test

2) Injury-surgery

3) Surgery-test (mean ± SD/median [range])

Associated injuries

Balance task

Measures/device considered

Clark et al. [13]

Australia

ACLR, ST

R/L: 19/24

PRP

45

30 male

15 female

26.0 ± 9.8

(15–53 years)

2) 3.8 ± 3.77 months

(0.32–23.97 months)

3) 10.72 ± 4.25 months

(5.65–20.4 months)

Meniscus repair (n = 10)

SLS, flexion, EO

3 × 30 s

Sway amplitude mean velocity

Wii Balance Board

Healthy matched controls

45

30 male

15 female

26.4 ± 9.8

(15–52 years)

 

N

Dauty et al. [16]

France

ACLR, PT/ST

R/L: 21/14

PRP

35

26 male

9 female

25.5 ± 5.8

1) 7.4 months

(1–13 months)

NR

SLS, flexion, EO

3 × 12 s

Sway area

AP path length

ML path length

Medicapteurs QFP stabilometric platform

Healthy controls

35

26 male

9 female

24.9 ± 5.9

 

N

Fernandes et al. [18]

Brazil

ACLD, CT

14 DL

PRP

14

11 male

3 female

25.0 ± 7.2

1) 9.29 ± 9.59 months

(3–18 months)

N

SLS, EO

3 × 30 s

Sway area

AP amplitude

ML amplitude

Sway velocity

Loran engineering EPS pressure platform

Healthy controls

14

10 male

4 female

25.0 ± 2.8

 

N

Hoffman et al. [27]

USA

ACLR, PT

20

8 male

12 female

23.4 ± 5.79

2) 9.52 months

(3–30 months)

CD

SLS, EO

4 × 20 s

Sway path linear mean

Kistler force plate

Healthy matched controls

20

13 male

7 female

24.0 ± 4.07

 

CD

Kouvelioti et al. [33]

Greece

ACLR, ST

PRP

15

NR

24.37 ± 3.50

3) 24 months

NR

SLS, front raise, EO

1 × 30 s

Sway area

AMTI AccuSway force platform

Healthy controls

10

NR

26.75 ± 2.37

 

N

Mohammadi et al. [38]

Iran

ACLR, PT/ST

DL/nDL: 16/12

PRP

30

22 male

8 female

25.0 ± 2.7

3) 8.4 ± 1.8 months

(6–10 months)

Meniscus injury (n = 16)

SLS, flexion, EO

3 × 30 s

AP sway amplitude

ML sway amplitude

AP sway velocity

ML sway velocity

mean velocity

Kistler force plate

Healthy matched controls

30

24 male

6 female

24.8 ± 2.4

 

N

Negahban et al. [40]

Iran

ACLD, CT

27

27 male

26.74 ± 5.84

1) 21.6 ± 26.76 months

NR

SLS, semiflexion, EO

3 × 20 s

Mean velocity

Bertec force platform

Healthy matched controls

27

27 male

26.29 ± 5.07

 

N

Sayuri Tookuni et al. [52]

Brazil

ACLD, CT

R/L: 8 ⁄ 11

PRP

19

18 male

1 female

15–33

NR

NR

SLS, flexion, EO

3 × 10 s

Total path length

AP path length

ML path length maximum speed

Tekscan F-Scan mat

Healthy controls

19

11 male,

8 female

18–30

 

N

Shiraishi et al. [53]

Japan

ACLR, IT

PRP

ACLD, CT

53

30

22 male

31 female

15 male

15 female

25.3 ± 6.6

(18–44)

23.7 ± 5.3

(18–39)

2) 25.2 ± 21.6 months

(0.25–84 months)

3) 45.6 ± 18 months

(24–72 months)

1) > 4 months

Meniscus injury (n = 33)

SLS front raise, EO

3 × 20 s

Total path length

ANIMA GS-10 Gravicorder

Healthy controls

30

15 male

15 female

22.7 ± 2.9

(19–29)

 

N

Soltani et al. [57]

Iran

ACLD copper CT

ACLD non-copper CT

5

10

NR

26.0 ± 3.0

24.0 ± 2.0

1) 18.2 ± 5.0 months

1) 13.0 ± 7.4 months

N

SLS, EO

5 × 10 s

Path line length

Sway velocity

Zebris platform

Healthy matched controls

15

NR

23.7 ± 2.4

 

N

Zouita Ben Moussa et al. [62]

Tunisia

ACLR, PT

26

NR

22.0 ± 3.11

3) 24 ± 0.25 months

NR

SLS, EO

3 × 10 s

Sway velocity

NeuroCom Balance Master platform

Healthy matched controls

20

NR

23.96 ± 2.02

 

N

  1. NR not reported, N no, CD cannot determine, ACLD anterior cruciate ligament deficient, ACLR anterior cruciate ligament reconstructed, CT conservative treatment, PT patellar tendon allograft/autograft, ST semitendinosus tendon allograft/autograft, IT iliotibial tract autograft, DL/nDL dominant leg/non-dominant leg injury, R/L right/left sided injury, PRP patients completed postsurgical rehabilitation program, SLS single-leg stance, EO eyes open, AP anteroposterior, ML mediolateral